AAAAAA

   
Results: 1-20 |
Results: 20

Authors: Isomaki, P Panesar, M Annenkov, A Clark, JM Foxwell, BMJ Chernajovsky, Y Cope, AP
Citation: P. Isomaki et al., Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface, J IMMUNOL, 166(9), 2001, pp. 5495-5507

Authors: Yamamoto, AM Chernajovsky, Y Lepault, F Podhajeer, O Feldmann, M Bach, JF Chatenoud, L
Citation: Am. Yamamoto et al., The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapy, J IMMUNOL, 166(8), 2001, pp. 4973-4980

Authors: Croxford, JL Feldmann, M Chernajovsky, Y Baker, D
Citation: Jl. Croxford et al., Different therapeutic outcomes in experimental allergic encephalomyelitis dependant upon the mode of delivery of IL-10: A comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervoussystem, J IMMUNOL, 166(6), 2001, pp. 4124-4130

Authors: Daly, G Chernajovsky, Y
Citation: G. Daly et Y. Chernajovsky, Recent developments in retroviral-mediated gene transduction, MOL THER, 2(5), 2000, pp. 423-434

Authors: Annenkov, A Chernajovsky, Y
Citation: A. Annenkov et Y. Chernajovsky, Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta, GENE THER, 7(8), 2000, pp. 714-722

Authors: Gould, DJ Berenstein, M Dreja, H Ledda, F Podhajcer, OL Chernajovsky, Y
Citation: Dj. Gould et al., A novel doxycycline inducible autoregulatory plasmid which displays 'on'/'off' regulation suited to gene therapy applications, GENE THER, 7(24), 2000, pp. 2061-2070

Authors: Croxford, JL Triantaphyllopoulos, KA Neve, RM Feldmann, M Chernajovsky, Y Baker, D
Citation: Jl. Croxford et al., Gene therapy for chronic relapsing experimental allergic encephalomyelitisusing cells expressing a novel soluble p75 dimeric TNF receptor, J IMMUNOL, 164(5), 2000, pp. 2776-2781

Authors: Adris, S Chuluyan, E Bravo, A Berenstein, M Klein, S Jasnis, M Carbone, C Chernajovsky, Y Podhajcer, OL
Citation: S. Adris et al., Mice vaccination with interleukin 12-transduced colon cancer cells potentiates rejection of syngeneic non-organ-related tumor cells, CANCER RES, 60(23), 2000, pp. 6696-6703

Authors: Dreja, H Annenkov, A Chernajovsky, Y
Citation: H. Dreja et al., Soluble complement receptor 1 (CD35) delivered by retrovirally infected syngeneic cells or by naked DNA injection prevents the progression of collagen-induced arthritis, ARTH RHEUM, 43(8), 2000, pp. 1698-1709

Authors: Gould, DJ Annenkov, A Dreja, H Chernajovsky, Y
Citation: Dj. Gould et al., Experimental gene therapy of rheumatoid arthritis: Present and future, RRD IMMUNOL, 2, 2000, pp. 283-313

Authors: Chernajovsky, Y
Citation: Y. Chernajovsky, Gene transfer as therapy for rheumatoid arthritis: why, what and how?, RHEUMATOLOG, 38(9), 1999, pp. 804-806

Authors: Adris, SK Klein, S Jasnis, MA Chuluyan, E Ledda, MF Bravo, AI Carbone, C Chernajovsky, Y Podhajcer, OL
Citation: Sk. Adris et al., IL-10 expression by CT26 colon carcinoma cells inhibits their malignant phenotype and induces a T cell-mediated tumor rejection in the context of a systemic Th2 response, GENE THER, 6(10), 1999, pp. 1705-1712

Authors: Berenstein, M Adris, S Ledda, F Wolfmann, C Medina, J Bravo, A Mordoh, J Chernajovsky, Y Podhajcer, OL
Citation: M. Berenstein et al., Different efficacy of in vivo herpes simplex virus thymidine kinase gene transduction and ganciclovir treatment on the inhibition of tumor growth of murine and human melanoma cells and rat glioblastoma cells, CANC GENE T, 6(4), 1999, pp. 358-366

Authors: Chernajovsky, Y Gould, D Annenkov, A Dreja, H Daly, G Rabinovich, GA Croxford, L Baker, D Berenstein, M Podhajcer, O
Citation: Y. Chernajovsky et al., Immunotherapy of auto-immune diseases by gene transfer, BIOCH SOC T, 27, 1999, pp. 869-873

Authors: Kissonerghis, M Daly, G Feldmann, M Chernajovsky, Y
Citation: M. Kissonerghis et al., The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer, MOL IMMUNOL, 36(2), 1999, pp. 125-134

Authors: Chernajovsky, Y
Citation: Y. Chernajovsky, Systemic gene therapy for arthritis, DRUGS TODAY, 35(4-5), 1999, pp. 361-377

Authors: Triantaphyllopoulos, KA Williams, RO Tailor, H Chernajovsky, Y
Citation: Ka. Triantaphyllopoulos et al., Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy, ARTH RHEUM, 42(1), 1999, pp. 90-99

Authors: Gould, DJ Foxwell, BMJ Feldmann, M Chernajovsky, Y
Citation: Dj. Gould et al., Potentiation of TNF-alpha toxicity by conjugation with ricin A-chain, CYTOKINE, 10(12), 1998, pp. 931-939

Authors: Mageed, RA Adams, G Woodrow, D Podhajcer, OL Chernajovsky, Y
Citation: Ra. Mageed et al., Prevention of collagen-induced arthritis by gene delivery of soluble p75 tumour necrosis factor receptor, GENE THER, 5(12), 1998, pp. 1584-1592

Authors: Annenkov, AE Moyes, SP Eshhar, Z Mageed, RA Chernajovsky, Y
Citation: Ae. Annenkov et al., Loss of original antigenic specificity in T cell hybridomas transduced with a chimeric receptor containing single-chain Fv of an anti-collagen antibody and Fc epsilon RI-signaling gamma subunit, J IMMUNOL, 161(12), 1998, pp. 6604-6613
Risultati: 1-20 |